Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Nov 10;9(11):e22221.
doi: 10.1016/j.heliyon.2023.e22221. eCollection 2023 Nov.

Coronavirus disease 2019 in a patient with pulmonary fibrosis and emphysema: An autopsy report

Affiliations
Case Reports

Coronavirus disease 2019 in a patient with pulmonary fibrosis and emphysema: An autopsy report

Risa Kudo et al. Heliyon. .

Abstract

Various diseases (e.g., hypertension and diabetes) are risk factors for the exacerbation of coronavirus 2019 (COVID-19). Patients with chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) tend to develop severe COVID-19. Patients with severe COVID-19 present with acute respiratory distress syndrome (ARDS), and many COVID-19-related ARDS survivors eventually develop fibrosis. However, the appropriate management of patients with COVID-19 and ILD and post-COVID-19 ILD remains unclear. Thus, a better understanding of the pathology that exacerbates COVID-19 in patients with ILD is needed. We report the autopsy results of a patient with COVID-19 and combined pulmonary fibrosis and emphysema, whose lung organization and fibrosis progressed after the acute phase of infection. Histopathological findings suggest that fatal pulmonary fibrosis persists after the negative conversion of SARS-CoV-2. Elucidating the cause of death by autopsy may help determine therapeutic strategies in patients with COVID-19 and ILD. Vaccination and early administration of anti-inflammatory drugs or antifibrotic agents may be crucial for preventing disease progression and fatal lung fibrosis. This report aims to clarify the histopathological features of COVID-19 in patients with ILD via autopsy and discuss treatment strategies.

Keywords: Acute respiratory distress syndrome; Autopsy; COVID-19; Interstitial lung disease; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Antemortem chest radiograph and CT scan findings. (A, B) CT scan on Day 4 reveals emphysema in both the upper and middle lobes and ground glass opacities and fibrosis mainly in the bilateral lower lobes. (C) Chest radiograph on Day 6 shows hyperlucency in the right upper lung field and ground glass opacities in both lower lung fields. CT, computed tomography.
Fig. 2
Fig. 2
Clinical course of the patient.
Fig. 3
Fig. 3
A chest computed tomography scan 2 hours after death shows (A) worsened emphysema in the right upper lobe and (B) dense infiltration and traction bronchiectasis in the bilateral lower lobes.
Fig. 4
Fig. 4
Pathologic findings of the lungs and trachea on autopsy in a Japanese man who died from COVID-19. (A) Gross findings show congested lungs and marked emphysematous changes mainly in the upper lung lobes. Microscopic lung findings show (B) organization in the left upper lobe, (C) accumulation of neutrophils in an organized air cavity in the right lower lobe, (D) neutrophilic infiltration in the tracheal mucosa, and (E) thrombus in a pulmonary vessel. (Hematoxylin and eosin stain; B, D, and E × 200; C × 40).

Similar articles

References

    1. World Health Organization Novel coronavirus situation report 2019-nCoV; 1. 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/2...
    1. Lee H., Choi H., Yang B., et al. Interstitial lung disease increases susceptibility to and severity of COVID-19. Eur. Respir. J. 2021;58 doi: 10.1183/13993003.04125-2020. - DOI - PMC - PubMed
    1. Beltramo G., Cottenet J., Mariet A.S., et al. Chronic respiratory diseases are predictors of severe outcome in COVID-19 hospitalised patients: a nationwide study. Eur. Respir. J. 2021;58 doi: 10.1183/13993003.04474-2020. - DOI - PMC - PubMed
    1. Shanmugam C., Mohammed A.R., Ravuri S., Luthra V., Rajagopal N., Karre S. COVID-2019 - a comprehensive pathology insight. Pathol. Res. Pract. 2020;216 doi: 10.1016/j.prp.2020.153222. - DOI - PMC - PubMed
    1. Guler S.A., Ebner L., Aubry-Beigelman C., et al. Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study. Eur. Respir. J. 2021;57 doi: 10.1183/13993003.03690-2020. - DOI - PMC - PubMed

Publication types

LinkOut - more resources